HK1204992A1 - Topical ophthalmological pharmaceutical composition containing sunitinib - Google Patents

Topical ophthalmological pharmaceutical composition containing sunitinib

Info

Publication number
HK1204992A1
HK1204992A1 HK15105934.1A HK15105934A HK1204992A1 HK 1204992 A1 HK1204992 A1 HK 1204992A1 HK 15105934 A HK15105934 A HK 15105934A HK 1204992 A1 HK1204992 A1 HK 1204992A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
composition containing
ophthalmological pharmaceutical
topical ophthalmological
containing sunitinib
Prior art date
Application number
HK15105934.1A
Other languages
English (en)
Chinese (zh)
Inventor
Michael Bttger
Degenfeld Georges Von
Julia Freundlieb
Claudia Hirth-Dietrich
Joerg Keldenich
Jrgen Klar
Uwe Muenster
Andreas Ohm
Annett Richter
Bernd Riedl
Joachim Telser
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/062365 external-priority patent/WO2013000917A1/en
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of HK1204992A1 publication Critical patent/HK1204992A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK15105934.1A 2012-06-25 2015-06-23 Topical ophthalmological pharmaceutical composition containing sunitinib HK1204992A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
PK40512 2012-06-25
PCT/EP2012/062365 WO2013000917A1 (en) 2011-06-28 2012-06-26 Topical ophthalmological pharmaceutical composition containing regorafenib
VE81612 2012-06-27
JOP20120170 2012-06-27
EP12198651 2012-12-20
PCT/US2013/044953 WO2013188283A1 (en) 2012-06-12 2013-06-10 Topical ophthalmological pharmaceutical composition containing sunitinib

Publications (1)

Publication Number Publication Date
HK1204992A1 true HK1204992A1 (en) 2015-12-11

Family

ID=49758933

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105934.1A HK1204992A1 (en) 2012-06-25 2015-06-23 Topical ophthalmological pharmaceutical composition containing sunitinib

Country Status (7)

Country Link
US (1) US20150174096A1 (xx)
EP (1) EP2858628A1 (xx)
JP (1) JP2017512748A (xx)
CN (1) CN104582685A (xx)
CA (1) CA2876311A1 (xx)
HK (1) HK1204992A1 (xx)
WO (1) WO2013188283A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201791337A1 (ru) * 2014-12-15 2017-11-30 Дзе Джонс Хопкинс Юниверсити Составы сунитиниба и способы их применения в лечении глазных нарушений
MX2017015838A (es) * 2015-06-06 2018-08-15 Cloudbreak Therapeutics Llc Composiciones y metodos para tratar pterigion.
TWI664965B (zh) 2015-06-22 2019-07-11 新源生物科技股份有限公司 酪胺酸激酶抑制劑之眼用調配物、其使用方法、及其製備方法
EA038755B1 (ru) 2015-11-12 2021-10-14 Грейбаг Вижн, Инк. Агрегирующие микрочастицы для обеспечения замедленного высвобождения терапевтического агента для внутриглазной доставки
BR112018074450A2 (pt) 2016-06-02 2019-03-19 Cloudbreak Therapeutics, Llc composições e métodos para a utilização de nintedanib para melhorar o sucesso da cirurgia do glaucoma
BR112019019452A2 (pt) 2017-03-23 2020-04-14 Graybug Vision Inc composto, e, uso de um composto
WO2018182527A1 (en) * 2017-03-30 2018-10-04 National University Of Singapore Method for treating inflammatory complications in eye diseases
AU2018265415A1 (en) 2017-05-10 2019-10-31 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
KR20240028815A (ko) 2022-08-25 2024-03-05 주식회사 스카이테라퓨틱스 약리 활성 물질의 신규 분자회합체 및 이를 포함하는 약학 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080011310A (ko) 2005-05-10 2008-02-01 알콘, 인코퍼레이티드 폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도
CN101163473A (zh) * 2005-05-12 2008-04-16 辉瑞大药厂 使用舒尼替尼苹果酸盐的抗癌组合疗法
US20080193448A1 (en) * 2005-05-12 2008-08-14 Pfizer Inc. Combinations and Methods of Using an Indolinone Compound
JP2008543775A (ja) 2005-06-08 2008-12-04 ターゲジェン インコーポレーティッド 眼の障害を治療するための方法および組成物
WO2007038453A2 (en) * 2005-09-26 2007-04-05 Advanced Ocular Systems Limited Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
PT1968594E (pt) 2005-11-29 2010-11-18 Glaxosmithkline Llc Tratamento de distúrbios neovasculares oculares tais como degeneração macular, estrias angióides, uveite e edema macular
WO2007076358A1 (en) 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
WO2008027341A2 (en) 2006-08-30 2008-03-06 Merck & Co., Inc. Topical ophthalmic formulations
EP2098521A1 (en) * 2008-03-06 2009-09-09 Ratiopharm GmbH Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation
WO2010017541A2 (en) * 2008-08-08 2010-02-11 The Johns Hopkins University Compositions and methods for treatment of neurodegenerative disease
CA2760687A1 (en) 2009-05-01 2010-11-04 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
WO2011009016A1 (en) 2009-07-16 2011-01-20 Glaxo Wellcome Manufacturing Pte Ltd Treatment method
ES2564502T3 (es) 2010-03-17 2016-03-23 Novaliq Gmbh Composición farmacéutica para el tratamiento de la presión intraocular aumentada

Also Published As

Publication number Publication date
CN104582685A (zh) 2015-04-29
JP2017512748A (ja) 2017-05-25
EP2858628A1 (en) 2015-04-15
CA2876311A1 (en) 2013-12-19
WO2013188283A8 (en) 2017-03-23
WO2013188283A1 (en) 2013-12-19
US20150174096A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
HK1206297A1 (en) Pharmaceutical compositions for combination therapy
PL3181122T3 (pl) Kompozycja farmaceutyczna dazatynibu
ZA201501930B (en) Pharmaceutical composition
HK1204564A1 (en) Topical ophthalmological pharmaceutical composition containing axitinib
HK1204563A1 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
HK1204992A1 (en) Topical ophthalmological pharmaceutical composition containing sunitinib
EP2832730A4 (en) MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION
HRP20190050T1 (hr) Farmaceutski pripravci za kombinacijsku terapiju
IL266415A (en) Innovative pharmaceutical composition
HK1197176A1 (en) Topical ophthalmological pharmaceutical composition containing regorafenib
HK1210711A1 (en) Pharmaceutical composition comprising rebamipide
ZA201505196B (en) Topical ophthalmological pharmaceutical composition containing regorafenib
HK1204289A1 (en) Topical ophthalmological pharmaceutical composition containing cediranib
ZA201502987B (en) Pharmaceutical composition
EP2851074A4 (en) ANALGETIC PHARMACEUTICAL COMPOSITION
EP2883546A4 (en) NOVEL DIFFERENTIALLY RELEASING PHARMACEUTICAL COMPOSITION CONTAINING THREE ACTIVE INGREDIENTS
EP2897590A4 (en) PHARMACEUTICAL COMPOSITION
EP2851078A4 (en) PHARMACEUTICAL COMPOSITION
EP2930175A4 (en) NOVEL OCTAHYDROPYRIDOQUINAZOLINE DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USES THEREFOR, AND THE DERIVATIVE THEREOF
ZA201400751B (en) Pharmaceutical composition
AU2012904295A0 (en) Pharmaceutical composition
GB201221130D0 (en) New pharmaceutical composition
HUE043019T2 (hu) Gyógyszerészeti készítmények kombinációs terápia céljára
GB201207628D0 (en) New pharmaceutical composition
GB201207701D0 (en) New pharmaceutical composition